Skip to main content
. 2016 Jul 11;7(34):55276–55289. doi: 10.18632/oncotarget.10527

Figure 1. CD171 expression in neural, neuroectodermal and neuroendocrine tumors.

Figure 1

A. Schwannoma showed diffuse and strong CD171 expression. B. Malignant peripheral nerve sheath tumor showed weak CD171 expression. C and D. Blastema component of neuroblastoma (C) and paraganglioma (D) diffusely expressed CD171. E and F. Merkel cell carcinoma (E) and small cell carcinoma of lung (F) also showed CD171 expression.